PAIGE LEYKAM: Open Payments
NPI 1033470968 · SURPRISE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,090 in 203 payments from 50 companies in 2025. Trend: 2023 $4,910 · 2024 $6,265 · 2025 $5,090
Food & beverage: $4,674Education: $429
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 21 | $622 |
| E.R. Squibb & Sons, L.L.C. | 16 | $341 |
| Novartis Pharmaceuticals Corporation | 13 | $278 |
| ABBVIE INC. | 11 | $244 |
| Daiichi Sankyo Inc. | 9 | $243 |
| Janssen Biotech, Inc. | 10 | $218 |
| GENZYME CORPORATION | 7 | $209 |
| SOBI, INC | 10 | $202 |
| Incyte Corporation | 6 | $188 |
| Genmab U.S., Inc. | 3 | $181 |
Products named: EPKINLY, OPDIVO, Enhertu, KEYTRUDA, FOTIVDA, IMFINZI, OJJAARA, CABOMETYX.
Industry payments across AZ — which companies pay providers there.
